Cannabix Technologies ( (TSE:BLO) ) has shared an announcement.
Cannabix Technologies Inc. and Omega Laboratories have successfully validated a marijuana breath test method that quantifies THC and other cannabinoids using Cannabix’s Breath Collection Unit. This collaboration marks a significant advancement in drug testing technology, offering a rapid and precise solution for detecting recent marijuana use, which is particularly relevant in the context of increasing cannabis legalization. The integration of Cannabix’s technology with Omega’s testing protocols enhances the accuracy and reliability of cannabis testing, providing a critical tool for industries facing challenges in detecting recent marijuana use.
More about Cannabix Technologies
Cannabix Technologies Inc. operates in the drug testing industry, focusing on the development of marijuana breath detection technology. The company collaborates with Omega Laboratories to enhance its Breath Collection Unit (BCU) for accurate and non-invasive THC detection, targeting markets such as law enforcement, workplace safety, and healthcare.
YTD Price Performance: 53.75%
Average Trading Volume: 101,487
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $43.48M
For an in-depth examination of BLO stock, go to TipRanks’ Stock Analysis page.